Last reviewed · How we verify
Placebo (for Lidocaïne)
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.
A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control comparator in clinical trials evaluating Lidocaïne efficacy.
At a glance
| Generic name | Placebo (for Lidocaïne) |
|---|---|
| Also known as | NaCl 0.9% |
| Sponsor | University of Liege |
| Modality | Small molecule |
| Therapeutic area | Clinical Trial Control |
| Phase | FDA-approved |
Mechanism of action
Placebo is an inert substance used as a control in clinical trials to assess the efficacy of active drugs. Any observed effects result from patient expectation, the therapeutic context, and natural disease progression rather than direct molecular action. In this case, it serves as a comparator to evaluate the local anesthetic effects of Lidocaïne.
Approved indications
- Control comparator in clinical trials evaluating Lidocaïne efficacy
Common side effects
Key clinical trials
- Prospective Monocentric Study on the Efficacy of Lidocain Spray for Patient Comfort During Nasogastric Tube Insertion in Enteral Nutrition (PHASE3)
- Lidocaine and Food Intake (PHASE4)
- Perioperative Lignocaine and Sleep Disturbance (PHASE4)
- Local Anesthesia Before Arterial Puncture for Blood Gas Analysis (PHASE3)
- Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (for Lidocaïne) CI brief — competitive landscape report
- Placebo (for Lidocaïne) updates RSS · CI watch RSS
- University of Liege portfolio CI